⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 9, 2012ThoraxOpen Access

Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

Athol U. Wells Ulrich Costabel Vincent Cottin Venerino Poletti Luca Richeldi

View Full Paper

Ask AI

Bookmark

Share

Abstract

Comment in "Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?" [Thorax. 2013]

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wells et al. (2012) studied this question.

synapsesocial.com/papers/6aa9ee5c663efc0f70843f6d https://doi.org/10.1136/thoraxjnl-2012-202580

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Randomised pilot and feasibility study comparing video-assisted thoracoscopic partial pleurectomy-decortication with indwelling pleural catheter for trapped lung in pleural mesotheliomaThorax · Tue,
2Impact of timing of interstitial lung disease in patients with systemic sclerosisThorax · Tue,
3Effects of acetazolamide on respiratory events and sleep in highlanders with obstructive sleep apnoea: a randomised controlled trialThorax · Tue,
4Lung function trajectories after pulmonary tuberculosis in children and adolescents: a prospective cohort studyThorax · Fri,
5End of rarity: the evolving burden of interstitial lung diseases in England – trends from a national population-based cohort studyThorax · Thu,

More from Thorax

Stakeholder-informed prioritisation of HealthTech innovation across chronic respiratory disease: the HERON studyWed,
Effects of obstructive sleep apnoea treatment on cardiovascular and sleep health in bed partners: the sleep partners clinical trialTue,
Systematic misclassification of lung function in Indian adolescents using GLI-2012 reference equations: evidence from the multicity APEAL cohortTue,
PM 2.5 , O 3 and survival gains from China’s clean air actions among patients with lung cancer: a 20-year registry-based cohort study in BeijingWed,
Inequalities in chronic respiratory disease: working towards policy change?Tue,